Superman 90mg (Viagra / Cialis) – 50 Tablets

Superman 90mg is an oral dual PDE5 inhibitor blend formulation combining Sildenafil and Tadalafil, supplied in a 50 tablet pack for controlled laboratory and analytical applications. This compound is manufactured to maintain consistent dosage accuracy, stable composition, and reliable batch to batch uniformity.

Sildenafil and Tadalafil are widely referenced in pharmacological research environments where phosphodiesterase type 5 enzyme inhibition, cyclic GMP pathway modulation, vascular smooth muscle relaxation signaling, and comparative PDE5 inhibitor compound studies are being evaluated. The dual compound blend is studied in research contexts for its complementary inhibition profiles, combining Sildenafil’s fast acting onset and peak plasma concentration characteristics with Tadalafil’s extended half life and prolonged receptor occupancy profile, providing a broad spectrum PDE5 inhibition research model within controlled in vitro and in vivo settings.

The 90mg formulation represents a modified compound concentration relative to the Superman V2 130mg variant, supporting research protocols requiring comparative dose response evaluations, lower concentration baseline studies, and structured pharmacokinetic profiling across dual PDE5 inhibitor blend variants. Each tablet is formulated to deliver accurate compound concentration for repeatable experimental application.

The 50 tablet pack format supports extended research procurement, allowing laboratories to maintain consistent compound availability across ongoing study protocols, comparative compound evaluations, and structured experimental timelines.

Each batch is produced under strict quality control standards to ensure purity, stability, and dependable performance across laboratory applications. The formulation is designed to maintain predictable dual PDE5 inhibition and vascular smooth muscle activity characteristics within controlled environments.

Key Features:

• Buy Superman 90mg: Dual PDE5 inhibitor oral tablet formulation combining Sildenafil and Tadalafil for pharmacological research
• 90mg Tablet Strength: Modified compound concentration for dose response and comparative pharmacokinetic research protocols
• 50 Tablet Pack: Extended bulk format for ongoing research protocols and comparative studies
• Sildenafil Component: Fast acting PDE5 inhibitor with peak plasma concentration and cyclic GMP modulation profile
• Tadalafil Component: Extended half life PDE5 inhibitor with prolonged receptor occupancy and vascular activity profile
• Dual PDE5 Inhibition Profile: Complementary broad spectrum phosphodiesterase inhibition research model
• Nitric Oxide Pathway Activity: Vascular smooth muscle relaxation and penile tissue signaling characteristics
• Consistent Batch Quality: Manufactured for repeatability and uniformity
• Stable Oral Formulation: Designed for reliable storage and handling
• Secure Packaging: Maintains product integrity and stability

Each package is clearly labeled for identification and traceability, supporting accurate handling and standardized use within research environments.